Division of Nephrology-Hypertension, University of California, San Diego, San Diego, CA.
Department of Laboratory Medicine and the Kidney Research Institute, University of Washington, Seattle, WA.
Clin Chem. 2021 Jan 30;67(2):385-393. doi: 10.1093/clinchem/hvaa238.
25-Hydroxyvitamin D [25(OH)D] may be a poor marker of vitamin D status as it reflects differences in vitamin D binding protein (VDBP) between individuals. The vitamin D metabolite ratio [VMR, ratio of 24,25(OH)2D3 to 25(OH)D3] is a marker of vitamin D status that has been hypothesized to be independent of variability in VDBP. This hypothesis has not been directly evaluated.
We measured 25(OH)D3, 24,25(OH)2D3, 1,25(OH)2D3, and VDBP in 377 community-dwelling older adults that participated in the Health Aging and Body Composition Study. 24,25(OH)2D3 and 25(OH)D3 were used to calculate the VMR. We used linear regression to assess the relationship between VDBP with the VMR, 24,25(OH)2D3, 25(OH)D3, and 1,25(OH)2D3.
Participants had mean age 75 ± 3 years, 52% were female, 40% were black, and 24% had chronic kidney disease. VDBP concentrations were associated with sex, serum albumin, and VDBP phenotype in multivariable models. In fully adjusted models, each 1% higher VDBP was associated with a 0.92%[95% CI(0.37,1.49%)], 0.76% (0.39, 1.13%), and 0.57% (0.29, 0.85%), higher 24,25(OH)2D3, 25(OH)D3, and 1,25(OH)2D3. The VMR was independent of VDBP concentration, [0.16%(-0.11, 0.44) higher VMR per 1% higher VDBP, P = .25].
The VMR was independent of VDBP concentration, whereas VDBP was strongly directly associated with the individual vitamin D metabolite concentrations. Prior studies evaluating only 25(OH)D3 may have been confounded by absence of data on VDBP status. The VMR may serve as an important biomarker of vitamin D status and clinical outcomes that can be utilized in populations with a large spectrum of VDBP concentrations.
25-羟维生素 D [25(OH)D] 可能不是维生素 D 状态的良好标志物,因为它反映了个体之间维生素 D 结合蛋白 (VDBP) 的差异。维生素 D 代谢物比值 [VMR,24,25(OH)2D3 与 25(OH)D3 的比值] 是维生素 D 状态的标志物,据推测它不受 VDBP 变异性的影响。这一假设尚未得到直接评估。
我们测量了参加健康老龄化和身体成分研究的 377 名社区居住的老年人的 25(OH)D3、24,25(OH)2D3、1,25(OH)2D3 和 VDBP。24,25(OH)2D3 和 25(OH)D3 用于计算 VMR。我们使用线性回归来评估 VDBP 与 VMR、24,25(OH)2D3、25(OH)D3 和 1,25(OH)2D3 之间的关系。
参与者的平均年龄为 75 ± 3 岁,52%为女性,40%为黑人,24%患有慢性肾脏病。在多变量模型中,VDBP 浓度与性别、血清白蛋白和 VDBP 表型相关。在完全调整的模型中,VDBP 每升高 1%,24,25(OH)2D3、25(OH)D3 和 1,25(OH)2D3 分别升高 0.92%(95%CI:0.37,1.49%)、0.76%(0.39,1.13%)和 0.57%(0.29,0.85%)。VMR 与 VDBP 浓度无关,[VDBP 每升高 1%,VMR 升高 0.16%(-0.11,0.44),P=0.25]。
VMR 与 VDBP 浓度无关,而 VDBP 与个体维生素 D 代谢物浓度密切相关。以前仅评估 25(OH)D3 的研究可能由于缺乏 VDBP 状态数据而受到混淆。VMR 可能是维生素 D 状态和临床结果的重要生物标志物,可用于 VDBP 浓度范围广泛的人群。